Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Geiger

Showing results (191-200 of 227) with videos related to

Pageof 23
Sort By:
The Laryngoscope|November 1, 2017
A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancerRichard Blake Ross, Shlomo A Koyfman, Chandana A Reddy, et al.
Environmental Toxicology and Chemistry|August 9, 2001
An assessment of the toxicity of phthalate esters to freshwater benthos. 2. Sediment exposuresD J Call, D A Cox, D L Geiger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2026
Enfortumab vedotin plus pembrolizumab as first-line treatment in recurrent or metastatic head and neck squamous cell carcinoma: results from EV-202 cohort 9Paul L Swiecicki, Glenn J Hanna, Jessica L Geiger, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 1, 2022
Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive NomogramShannon S Wu, Nikhil Joshi, Jonathan Sharrett, et al.
Head & Neck|November 27, 2019
Impact of active smoking on outcomes in HPV+ oropharyngeal cancerRoy Xiao, Yvonne Pham, Matthew C Ward, et al.
Head & Neck|January 18, 2022
Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institutionShannon S Wu, Bonnie Chen, Christopher W Fleming, et al.
Oral Oncology|January 29, 2014
Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinomaJessica L Geiger, Ahmed F Lazim, Francis J Walsh, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional ExperienceN Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Oral Oncology|November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 studyKevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
Anticancer Research|October 1, 2021
Updated Outcomes of Split Course Radiotherapy in Elderly or Infirm Patients With Advanced Cancers of the Head and NeckChaim Domb, Timothy D Smile, Chandana Reddy, et al.
Pageof 23

Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
The Laryngoscope|November 1, 2017
A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancerRichard Blake Ross, Shlomo A Koyfman, Chandana A Reddy, et al.
Environmental Toxicology and Chemistry|August 9, 2001
An assessment of the toxicity of phthalate esters to freshwater benthos. 2. Sediment exposuresD J Call, D A Cox, D L Geiger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2026
Enfortumab vedotin plus pembrolizumab as first-line treatment in recurrent or metastatic head and neck squamous cell carcinoma: results from EV-202 cohort 9Paul L Swiecicki, Glenn J Hanna, Jessica L Geiger, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 1, 2022
Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive NomogramShannon S Wu, Nikhil Joshi, Jonathan Sharrett, et al.
Head & Neck|November 27, 2019
Impact of active smoking on outcomes in HPV+ oropharyngeal cancerRoy Xiao, Yvonne Pham, Matthew C Ward, et al.
Head & Neck|January 18, 2022
Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institutionShannon S Wu, Bonnie Chen, Christopher W Fleming, et al.
Oral Oncology|January 29, 2014
Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinomaJessica L Geiger, Ahmed F Lazim, Francis J Walsh, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional ExperienceN Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Oral Oncology|November 23, 2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 studyKevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, et al.
Anticancer Research|October 1, 2021
Updated Outcomes of Split Course Radiotherapy in Elderly or Infirm Patients With Advanced Cancers of the Head and NeckChaim Domb, Timothy D Smile, Chandana Reddy, et al.
Pageof 23